Medtronic PLC
I · AI-analyse
In het kort
Medtronic manufactures and sells medical devices across four main areas: heart devices like pacemakers and heart valves, neuroscience products including spinal implants and brain stimulation systems, surgical tools including robotic-assisted surgery platforms, and diabetes management products like insulin pumps and glucose monitors [Company Overview]. The company serves hospitals, physicians, and patients in over 150 countries worldwide.
Medtronic is a major medical device company that makes cardiac devices, spinal implants, surgical tools, and diabetes management systems. The company faces moderate financial health concerns with slowing growth and operational inefficiencies [Yahoo Finance], but it maintains a 48-year dividend growth streak and is investing in AI-powered surgical robotics [Yahoo Finance]. Recent news highlights leadership changes in key divisions and positive momentum in new therapy development [Simply Wall St, Yahoo Finance].
Medtronic shows moderate financial concerns with slow growth and modest returns despite strong cash flow generation.
Sentinellis-score
5.3/10
Moderate concerns
Marktkapitalisatie
$100.9B
Omzet (12 maanden)
$33.5B
II · Recent nieuws
Wat de koers bewoog
6 stories · ranked by relevance
- macro2026-05-18
Mental Health Matters at Medtronic. Explore Our Employee Benefits
Yahoo Finance
- macro2026-05-19
Medtronic Neuroscience Appointment Puts Focus On Execution And Growth Risks
Simply Wall St
- macro2026-05-18
Medtronic (MDT) Advances While Market Declines: Some Information for Investors
Yahoo Finance
- macro2026-05-18
Middle East and Africa Wearable Injectors Market Trends and Forecast Report 2026-2035 Featuring Amgen, BD, Biocon, Gerresheimer, Insulet, J&J, Medtronic, Roche, West Pharmaceutical, Ypsomed
Yahoo Finance
- macro2026-05-17
A Once-in-a-Decade Opportunity: 1 Stock to Buy Hand Over Fist and Hold for Years
Yahoo Finance
- macro2026-05-14
Should Medtronic’s AVIM Hypertension Trial Shift Require Action From Medtronic (MDT) Investors?
Yahoo Finance
Premium · gratis met elk account
Revenue growth of only 3.6% year-over-year is significantly slower than historical medtech sector averages, suggesting Medtronic may be losing competitive ground [Yahoo Finance]
Risico's
5
Kansen
6
Waarschuwingssignalen
3
Leiding
10
Nog 23 bevindingen in het volledige rapport — gratis met elk account.
Ontgrendel de volledige analyse van Medtronic PLC
Maak een gratis account voor het volledige AI-rapport met bronvermelding in de tekst.
- 5 risico's, 6 kansen en 3 waarschuwingssignalen — elk met zijn bron
- Meer dan 100 financiële cijfers met grafieken en vergelijkingen
- Volledige nieuwssamenvattingen met bronlinks
- Directie en beloning
- PDF-export voor offline
III · Vergelijkbare bedrijven
Misschien ook interessant
Same sector · Healthcare or comparable health
Op je volglijst zetten?